
Further sensitivity analyses to control for family alcohol consumption, family history, liver disease, and smoking, finds no convincing evidence that these factors affected the results.

Further sensitivity analyses to control for family alcohol consumption, family history, liver disease, and smoking, finds no convincing evidence that these factors affected the results.

Research suggests that individuals receiving a vaccine, such as ones from AstraZeneca and Johnson & Johnson, were more vulnerable to infection by new variants.

A new APPE rotation at the Xavier University of Louisiana College of Pharmacy allows students to explore the pharmaceutical supply chain and their role within it.

PQA wants to expand the types of services covered and report on the results of the current examples that are profiled in the SDOH guide.

Taking multiple prescription drugs and supplements can be especially dangerous for individuals with cancer who are about to undergo therapy.

The challenges in pharmacy are really a lack of standardization.

When both the clinical criteria and genetic testing were combined, 6.6 familial hypercholesterolemia cases per 1000 individuals screened were found.

Dimetapp is for cold and cough.

Symbyax combines olanzapine, an atypical antipsychotic, and fluoxetine, a selective serotonin reuptake inhibitor, indicated for acute treatment of depressive episodes associated with bipolar I disorder in adults.

Pharmacists are ideally positioned to screen patients for estimation aids and then refer them to services.

The use of cocaine can cause coronary artery vasospasm, which can lead to myocardial ischemia, acute coronary syndrome, and acute myocardial infarction.

Using machine learning, they find patterns in electronic health record data to help ascertain which individuals likely have the condition.

How would you handle these patients' questions?

Investigators establish 2 predictive models, which had excellent performance, and included 90 children.

Treatment with nirogacestat resulted in a 71% reduction in the risk of disease progression among adults with progressing desmoid tumors.

This month's generic product news features clarithromycin, sevelamer hydrochloride, and metronidazole.

Consequences for untreated STEMI patients following the COVID-19 pandemic could include increased mortality, heart failure, and morbidities.

Pharmacists are an important touch point for PQA, and they're starting small and thinking big.

Immunocompromised patients are particularly at risk of developing persistent and severe anemia caused by parvovirus infections.

Any antibiotic use was associated with higher rates of IBD, and the risk went up substantially with each course.

Allergic rhinitis and allergies can be serious conditions for some patients, but it is treatable with OTC products.

Linaclotide (Linzess) is indicated in adults for treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

PQA is also committed to national goals related to HIV and reducing HIV ending the epidemic.

CalmAid helps reduce stress and tension.

The approval is supported by data from a global phase 3 trial assessing the use of the drug for individuals with previously untreated IDH1-mutated acute myeloid leukemia.

Emflaza is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older.

With the new approval, manufacturers believe 7000 new rings will be able to enter the supply chain and will be available to customers in the second and third quarters of 2022.

PQA is focused on actually testing the feasibility and implementation of some of these measures as concepts.

Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how the use of artificial intelligence may help develop new drug therapies targeting multiple disease states.

Karen Fancher, PharmD, BCOP, a member of the Patient Advisory Panel at the Hematology/Oncology Pharmacy Association (HOPA), explains how her experience as a patient with cancer and an oncology pharmacy specialist informs her work on HOPA’s Patient Advisory Panel.